Turmeric Muscle Soreness Randomized Trial: What the Evidence Says

Quick Answer

Turmeric Muscle Soreness Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• These symptoms may disrupt training, impair performance, and increase the risk of injury. [Schönenberger Katja A. (2025); evidence level 2]
• Structural damage and secondary muscle injury are also associated with reductions in muscular strength, function, and range of motion (ROM), along with elevated levels of creatine kinase (CK), lactate dehydrogenase, myoglobin, and, to a lesser extent, transaminases (alanine and aspartate aminotransferases). [Schönenberger Katja A. (2025); evidence level 2]
• In addition to lowering the risk of metabolic syndrome and other serious chronic diseases, eating a healthy diet can increase longevity. [Katkar Rahul (2026); evidence level 3]
• These processes lead to impaired muscle protein synthesis, increased proteolysis, and reduced regenerative capacity of skeletal muscle. [Katkar Rahul (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For turmeric muscle soreness randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Schönenberger Katja A. (2025). A randomized, placebo-controlled, crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adults. DOI: 10.1080/15502783.2025.2568048. PMCID: PMC12498372. PMID: 41040018. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12498372/
• Katkar Rahul (2026). Efficacy of traditional Indian diet ( Ayush ahara ) on muscle strength and Sarcopenia: A scoping review. DOI: 10.1016/j.jaim.2025.101265. PMCID: PMC12874578. PMID: 41619563. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12874578/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.